In clinical trials, four in-development psychiatric drugs show promise for treatment of schizophrenia, postpartum depression and major depressive disorder, MDLinx reported July 21.
The Latest
Children are more likely to have an anxiety disorder if their same-sex parent has one, a study published by JAMA Open Network found.
Telehealth at-home ketamine therapy sessions are a safe and "incredibly effective" treatment for depression and anxiety, clinicians in charge of a recent study published in Journal of Affective Disorders reported.
Sens. Patty Murray and Ron Wyden of Washington and Oregon, respectively, are launching an investigation into abuse of children with special needs and mental health issues at residential treatment centers, NBC reported July 22.
FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety
The FDA has approved Neuronetics' transcranial magnetic stimulation system as a treatment for adults with major depressive disorder, the company said this week.
Psychiatrists at Duke University in Durham, N.C., spoke recently on the mental health crisis among adolescents, one calling it "unlike anything [he's] experienced."
New York City will spend $10.8 million to expand its free mental health helpline, NYC Well, Mayor Eric Adams said this week.
Levi Van Dyke, senior director of Volunteers of America Western Washington's 988 crisis contact centers, discussed the national suicide prevention lifeline's recent transition to a three digit number with Becker's July 19.
Wysa, an artificial intelligence digital mental health platform, nabbed $20 million in funding, the company said July 18.
UW Medicine is planning to build a 184,000-square-foot behavioral health teaching facility in Seattle that will also offer behavioral health treatment, local real estate news site the Registry reported July 21.